| ||||||||
|
||||||||
|
||||||||
|
||||||||
| Or | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "A"
Results 121 - 130 of 1915 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| Afghani, A C A Haiman, M C Pike, L Bernstein, S V Jaque, F Z Stanczyk, A Afghani, R K Peters, P Wan and L Shames Ethnic differences in ovulatory function in nulliparous women doi:10.1038/sj.bjc.6600098 Abstract | Full article | PDF |
||||||||
| Aft, R L R L Aft, F W Zhang and D Gius Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death doi:10.1038/sj.bjc.6600547 Abstract | Full article | PDF |
||||||||
| Agúndez, J A G C Martínez, E García-Martín, R M Pizarro, F J García-Gamito and J A G Agúndez Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy doi:10.1038/sj.bjc.6600494 Abstract | Full article | PDF |
||||||||
| Agarwal, R A E Guppy, A E Nelstrop, T Foster, R Agarwal, M J Seckl and G J S Rustin A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer doi:10.1038/sj.bjc.6601618 Abstract | Full article | PDF |
||||||||
| Agelaki, S K Kalbakis, Ch Kouroussis, S Kakolyris, D Mavroudis, J Souglakos, S Agelaki, L Vamvakas, M Christodoulakis, K Stylianou and V Georgoulias Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracyclin doi:10.1054/bjoc.2001.2001 Abstract | Full article | PDF |
||||||||
| Agelidou, A V Georgoulias, A Agelidou, K Syrigos, A Rapti, M Agelidou, J Nikolakopoulos, A Polyzos, A Athanasiadis, E Tselepatiotis, N Androulakis, K Kalbakis, G Samonis and D Mavroudis Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study advance online publication, 2005-09-20 00:00:00.000; doi:10.1038/sj.bjc.6602748 Abstract | Full article | PDF |
||||||||
| Agelidou, A V Georgoulias, C Kouroussis, A Agelidou, I Boukovinas, P Palamidas, E Stavrinidis, A Polyzos, K Syrigos, M Veslemes, M Toubis, A Ardavanis, E Tselepatiotis and I Vlachonikolis Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study advance online publication, 2004-07-06 00:00:00.000; doi:10.1038/sj.bjc.6602010 Abstract | Full article | PDF |
||||||||
| Agerbaek, M M Agerbaek, J Alsner, N Marcussen, F Lundbeck and H von der Maase Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer doi:10.1038/sj.bjc.6601063 Abstract | Full article | PDF |
||||||||
| Aglietta, M G Valabrega, F Fagioli, S Corso, E Madon, A Brach del Prever, E Biasin, A Linari, M Aglietta and S Giordano ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells doi:10.1038/sj.bjc.6600735 Abstract | Full article | PDF |
||||||||
| Agostino, M D F Emerich, P Snodgrass, R Dean, M Agostino, B Hasler, M Pink, H Xiong, B S Kim and R T Bartus Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters doi:10.1038/sj.bjc.6690450 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||